Xeltis prepares for commercial launch after strong aXess trial results - PharmaTimes EU phase 3 data shows major gains in dialysis access performance

#nephrology #Xeltis #aXesstrialresults #aXessclinicaltrial #phase3trial #restorativevascularaccess #vascularaccess #haemodialyisis #primaryendpoint #endstagerenaldisease #haemodiaylisisvascularaccesstreatment #EndogenousTissueRestorationplatform #vascularaccess #dialysispatients
zurl.co/UPkoj

Amgen and Kyowa Kirin announce rocatinlimab results for atopic dermatitis - PMLiVE The phase 3 study included around 2,600 patients

#Amgen #KyowaKirin #rocatinlimab #atopicdermatitis #phase3study #ASCENDstudy #Tcellrebalancingtherapy #OX40receptor #drugsafety #efficacy #ROCKETtrial #primaryendpoint #secondaryendpoints #HORIZONtrial #IGNITEtrial #rocatinlimabmonotherapy #OX40inhibition
pmlive.com/pharma_news/...

Lilly’s Jaypirca shows positive results in phase 3 trial - PharmaTimes Pirtobrutinib meets primary endpoint in CLL/SLL study

#oncology #Lilly #LillyOncology #Jaypirca #Pirtobrutinib #primaryendpoint #EliLilly #CLL313 #CLL314 #phase3 #BRUINCLL314trial #chroniclymphocyticleukaemia #CLL #smalllymphocyticlymphoma #SLL #noncovalentBTKinhibitor #Imbruvica #ibrutinib #covalentBTKinhibitor
pharmatimes.com/news/lillys-...

The phase 3 #IMPower151 trial evaluated atezolizumab + bevacizumab + CT (ABCPem/Pac) vs bevacizumab + CT (BCPem/Pac) in 305 Chinese pts with metastatic nsqNSCLC

#NatureMedicine @natureportfolio.nature.com

#Onco404 #Cancer #Kanser #LungCancer #Immunotherapy #ClinicalTrials #PrimaryEndpoint #MedSky

Tris Pharma announces positive results from ALLEVIATE-1 trial of cebranopadol - PharmaTimes Phase 3 trial shows promising pain relief for acute pain patients

#painmanagement #healthcare #pain #TrisPharma #ALLEVIATE1clinicaltrial #cebranopadol #Phase3trial #painrelief #acutepain #abdominoplasty #primaryendpoint #reducingpainintensity #Painintensity #NRSscale #analgesia #opioids #painmanagement #NDAsubmission
pharmatimes.com/news/tris-ph...